Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Medicine Manufacturing	4.23B	5.40B	4.51B	3.57B	3.05B
Medicine Manufacturing Growth	-21.68%	19.53%	26.32%	16.99%	-
Unallocated Other	389.55M	361.61M	308.58M	246.72M	177.08M
Unallocated Other Growth	7.73%	17.19%	25.07%	39.33%	-
Total	4.62B	5.76B	4.82B	3.82B	3.23B
Total Growth	-19.83%	19.38%	26.24%	18.21%	-3.98%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
North China	884.49M	1.51B	1.25B	1.15B	1.13B
North China Growth	-41.54%	21.20%	8.39%	1.94%	-
East China	1.87B	2.40B	2.17B	1.26B	668.49M
East China Growth	-22.06%	10.52%	71.85%	89.05%	-
Central China	230.71M	333.33M	103.19M	327.48M	304.87M
Central China Growth	-30.79%	223.03%	-68.49%	7.42%	-
Southwest	86.77M	82.17M	269.56M	249.51M	216.25M
Southwest Growth	5.60%	-69.52%	8.03%	15.38%	-
Northwest	405.23M	396.93M	310.97M	244.68M	229.38M
Northwest Growth	2.09%	27.64%	27.09%	6.67%	-
South China	490.59M	406.86M	78.73M	153.55M	54.30M
South China Growth	20.58%	416.80%	-48.73%	182.81%	-
Northeast	23.30M	102.50M	65.83M	134.33M	65.75M
Northeast Growth	-77.26%	55.71%	-51.00%	104.31%	-
Export	624.44M	523.33M	574.89M	295.41M	563.08M
Export Growth	19.32%	-8.97%	94.61%	-47.54%	-
Southeast	-	-	-	94.34K	14.13K
Southeast Growth	-	-	-	567.65%	-
Total	4.62B	5.76B	4.82B	3.82B	3.23B
Total Growth	-19.83%	19.38%	26.24%	18.21%	-11.44%

Source: S&P Global Market Intelligence.